0001178913-20-001359.txt : 20200507 0001178913-20-001359.hdr.sgml : 20200507 20200507203812 ACCESSION NUMBER: 0001178913-20-001359 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200507 FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harel Insurance Co LTD CENTRAL INDEX KEY: 0001666482 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 20858381 BUSINESS ADDRESS: STREET 1: ABBA HILLEL 3 CITY: RAMAT GAN STATE: L3 ZIP: 5211802 BUSINESS PHONE: 97237547090 MAIL ADDRESS: STREET 1: ABBA HILLEL 3 CITY: RAMAT GAN STATE: L3 ZIP: 5211802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harel Insurance Investments & Financial Services Ltd. CENTRAL INDEX KEY: 0001429390 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 20858382 BUSINESS ADDRESS: STREET 1: HAREL HOUSE, 3 ABBA HILLEL ST. CITY: RAMAT GAN STATE: L3 ZIP: 52118 BUSINESS PHONE: 972-3-7547090 MAIL ADDRESS: STREET 1: HAREL HOUSE, 3 ABBA HILLEL ST. CITY: RAMAT GAN STATE: L3 ZIP: 52118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001797336 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823578375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (857) 444-0553 MAIL ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 3 1 ownership.xml X0206 3 2020-05-07 0 0001797336 Ayala Pharmaceuticals, Inc. AYLA 0001666482 Harel Insurance Co LTD 3 ABA HILLEL ROAD STREET RAMAT GAN L3 52118 ISRAEL 0 0 1 0 0001429390 Harel Insurance Investments & Financial Services Ltd. 3 ABA HILLEL ROAD STREET RAMAT GAN L3 52118 ISRAEL 0 0 1 0 Common Stock, par value $0.01 per share 1094385 I See footnote Series A Preferred Stock, par value $0.01 per share Common Stock 307692 I See footnote Series B Preferred Stock, par value $0.01 per share Common Stock 211757 I See footnote Share numbers in this Statement give effect to the reverse split of each share of the Issuer's Common Stock into 0.5 shares of Common Stock, which will be effective for the shares of Series A Preferred Stock and Series B Preferred Stock (together, the "Preferred Stock") upon their conversion into Common Stock upon the closing of the Issuer's initial public offering. All of the shares of Common Stock and Preferred Stock reported in this Statement are directly held by Harel Insurance Company Ltd. ("Harel Insurance"), a wholly owned subsidiary of Harel Insurance Investments & Financial Services Ltd. ("Harel Holdings"), for Harel Insurance's own account. While Harel Insurance operates under independent management and makes independent voting and investment decisions, Harel Holdings may be deemed, by virtue of its ownership of Harel Insurance, to both beneficially own and have a pecuniary interest in all shares presently directly owned by Harel Insurance. The Preferred Stock have no expiration date and are convertible at any time at the election of the holder without payment of further consideration. Each share of Preferred Stock will automatically convert into one share of Common Stock upon the closing of the Issuer's initial public offering. HAREL INSURANCE COMPANY LTD. BY: /s/ Uri Rabinovitz, Vice President 2020-05-07 HAREL INSURANCE INVESTMENTS AND FINANCIAL SERVICES LTD. BY: /s/ Uri Rabinovitz, Vice President 2020-05-07